Abstract
AbstractIn the past decade, RNA therapeutics have gone from being a promising concept to one of the most exciting frontiers in healthcare and pharmaceuticals. The field is now entering what many call a renaissance or “RNAissance” which is being fueled by advances in genetic engineering and delivery systems to take on more ambitious development efforts. However, this renaissance is occurring at an unprecedented pace, which will require a different way of thinking if the field is to live up to its full potential. Recognizing this need, this article will provide a forward-looking perspective on the field of RNA medical products and the potential long-term innovations and policy shifts enabled by this revolutionary and game-changing technological platform.
Publisher
Springer Science and Business Media LLC
Reference145 articles.
1. Kim, Y. K. RNA therapy: rich history, various applications and unlimited future prospects. Exp. Mol. Med. 54, 455–465 (2022).
2. Damase, T. R. et al. The limitless future of RNA therapeutics. Front. Bioeng. Biotechnol. 9, 628137 (2021).
3. Lohr, A. 2023’s market outlook for cell and gene therapies, https://www.cellandgene.com/doc/s-market-outlook-for-cell-and-gene-therapies-0001 (2023).
4. Brenner, S., Jacob, F. & Meselson, M. An unstable intermediate carrying information from genes to ribosomes for protein synthesis. Nature 190, 576–581 (1961).
5. Martinon, F. et al. Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA. Eur. J. Immunol. 23, 1719–1722 (1993).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献